Xu Y - Search Results

1

A negative-doughnut distal resection margin less than 5 mm does not affect prognosis in rectal cancer.

Keranmu A, Liu HN, Wu YC, Liu TT, Li C, Guo TA, Liu FQ, Zheng HT, Xu Y. Keranmu A, et al. Among authors: xu y. J Surg Oncol. 2018 Sep;118(3):536-543. doi: 10.1002/jso.25161. J Surg Oncol. 2018. PMID: 30259516

2

Predicting prognosis of rectal cancer patients with total mesorectal excision using molecular markers.

Peng JJ, Cai SJ, Lu HF, Cai GX, Lian P, Guan ZQ, Wang MH, Xu Y. Peng JJ, et al. Among authors: xu y. World J Gastroenterol. 2007 Jun 7;13(21):3009-15. doi: 10.3748/wjg.v13.i21.3009. World J Gastroenterol. 2007. PMID: 17589956 Free PMC article.

3

Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer.

Peng J, Lu JJ, Zhu J, Xu Y, Lu H, Lian P, Cai G, Cai S. Peng J, et al. Among authors: xu y. Cancer J. 2008 Jan-Feb;14(1):54-61. doi: 10.1097/PPO.0b013e3181629a67. Cancer J. 2008. PMID: 18303484

4

Prognostic significance of the metastatic lymph node ratio in node-positive rectal cancer.

Peng J, Xu Y, Guan Z, Zhu J, Wang M, Cai G, Sheng W, Cai S. Peng J, et al. Among authors: xu y. Ann Surg Oncol. 2008 Nov;15(11):3118-23. doi: 10.1245/s10434-008-0123-8. Epub 2008 Sep 3. Ann Surg Oncol. 2008. PMID: 18769971

5

CXCL10 expression and prognostic significance in stage II and III colorectal cancer.

Jiang Z, Xu Y, Cai S. Jiang Z, et al. Among authors: xu y. Mol Biol Rep. 2010 Jul;37(6):3029-36. doi: 10.1007/s11033-009-9873-z. Epub 2009 Oct 10. Mol Biol Rep. 2010. PMID: 19821051

6

Analysis of RGS2 expression and prognostic significance in stage II and III colorectal cancer.

Jiang Z, Wang Z, Xu Y, Wang B, Huang W, Cai S. Jiang Z, et al. Among authors: xu y. Biosci Rep. 2010 Dec;30(6):383-90. doi: 10.1042/BSR20090129. Biosci Rep. 2010. PMID: 20001967

7

LAPTM4B overexpression is a novel predictor of epithelial ovarian carcinoma metastasis.

Yin M, Xu Y, Lou G, Hou Y, Meng F, Zhang H, Li C, Zhou R. Yin M, et al. Among authors: xu y. Int J Cancer. 2011 Aug 1;129(3):629-35. doi: 10.1002/ijc.25689. Epub 2010 Nov 28. Int J Cancer. 2011. PMID: 20857494

8

Down-regulated GAS1 expression correlates with recurrence in stage II and III colorectal cancer.

Jiang Z, Xu Y, Cai S. Jiang Z, et al. Among authors: xu y. Hum Pathol. 2011 Mar;42(3):361-8. doi: 10.1016/j.humpath.2010.03.009. Epub 2010 Nov 26. Hum Pathol. 2011. PMID: 21111449

9

Racial differences in MLH1 and MSH2 mutation: an analysis of yellow race and white race based on the InSiGHT database.

Wei W, Liu L, Chen J, Jin K, Jiang F, Liu F, Fan R, Cheng Z, Shen M, Xue C, Cai S, Xu Y, Nan P. Wei W, et al. Among authors: xu y. J Bioinform Comput Biol. 2010 Dec;8 Suppl 1:111-25. doi: 10.1142/s0219720010005154. J Bioinform Comput Biol. 2010. PMID: 21155023

10

Adjuvant therapy for T3N0 rectal cancer in the total mesorectal excision era- identification of the high risk patients.

Zhu J, Xu Y, Gu W, Peng J, Cai G, Cai G, Sun W, Shen W, Cai S, Zhang Z. Zhu J, et al. Among authors: xu y. Radiat Oncol. 2010 Dec 15;5:118. doi: 10.1186/1748-717X-5-118. Radiat Oncol. 2010. PMID: 21156077 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73,490 results

Search Page

Filters